Dopamine D2 receptors modulate the expression of contextual conditioned fear: Role of the ventral tegmental area and the basolateral amygdala

Behavioural Pharmacology

Volumn 24, Issue 4, 2013, Pages 264-274

  De Souza Caetano, Kátia A ^a,b   De Oliveira, Amanda R ^a,b   Brandão, Marcus L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Neurosciences and Behavior (INeC)   (Brazil)

Author keywords

Basolateral amygdala; Contextual fear conditioning; Dopamine receptors; Freezing response; Quinpirole; Rat; Sch23390; Skf38393; Sulpiride; Ventral tegmental area

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; QUINPIROLE; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FEAR; MOTOR PERFORMANCE; NONHUMAN; RAT; VENTRAL TEGMENTUM;

AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); DOPAMINE AGENTS; ELECTROSHOCK; EXPLORATORY BEHAVIOR; FEAR; FREEZING REACTION, CATALEPTIC; MALE; MICROINJECTIONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; VENTRAL TEGMENTAL AREA;

EID: 84880611864     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32836356c4     Document Type: Article

References (79)

1. Abercrombie ED, Keefe KA, Difrischia DS, Zigmond MJ (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52:1655-1658.
2. Albrechet-Souza L, Borelli KG, Almada RC, Brandão ML (2011). Midazolam reduces the selective activation of the rhinal cortex by contextual fear stimuli. Behav Brain Res 216:631-638.
3. Albrechet-Souza L, Carvalho MC, Brandão ML (2013). D1-like receptors in the nucleus accumbens shell regulate the expression of contextual fear conditioning and activity of the anterior cingulate cortex in rats. Int J Neuropsychopharmacol 16:1045-1057.
4. Bast T, Zhang WN, Feldon J (2001). The ventral hippocampus and fear conditioning in rats. Different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the GABA(A) agonist muscimol. Exp Brain Res 139:39-52.
5. Bast T, Zhang WN, Feldon J (2003). Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus 13:657-675.
6. Beckstead RM, Domesick VB, Nauta WJH (1979). Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175:191-217.
7. Blanchard DC, Blanchard RJ (1972a). Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 89:281-290.
8. Blanchard RJ, Blanchard DC (1972b). Effects of hippocampal lesions on the rat's reaction to a cat. J Comp Physiol Psychol 78:77-82.
9. Bolles RC, Collier AC (1976). The effect of predictive cues on freezing in rats. Anim Learn Behav 4:6-8.
10. Borowski TB, Kokkinidis L (1998). The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis. Behav Neurosci 112:952-965.
11. Brandão ML, Zanoveli JM, Ruiz-Martinez RC, Oliveira LC, Landeira-Fernandez J (2008). Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behav Brain Res 188:1-13.
12. Braun AR, Jaskiw GE, Vladar K, Sexton RH, Kolachana BS, Weinberger DR (1993). Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat. Pharmacol Biochem Behav 46:51-60.
13. Brinley-Reed M, McDonald AJ (1999). Evidence that dopaminergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res 850:127-135.
14. Callier S, Snapyan M, Crom S, Prou D, Vicent J, Vernier P (2003). Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell 95:489-502.
15. Carrive P (2000). Conditioned fear to environmental context: cardiovascular and behavioral components in the rat. Brain Res 858:440-445.
16. Carvalho JDM, de Oliveira AR, Silva CB, Brandão ML (2009). A comparative study on the effects of the benzodiazepine midazolam and the dopamine agents, apomorphine and sulpiride, on rat behavior in the two-way avoidance test. Pharmacol Biochem Behav 92:351-356.
17. Coco ML, Kuhn CM, Ely TD, Kilts CD (1992). Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam. Brain Res 590:39-47.
18. Corral-Frias NS, Lahood RP, Edelman-Vogelsang KE, French ED, Fellous JM (2013). Involvement of the ventral tegmental area in a rodent model of posttraumatic stress disorder. Neuropsychopharmacology 38:350-363.
19. Cuadra G, Zurita A, Macedo CE, Molina VA, Brandão ML (2000). Electrical stimulation of the midbrain tectum enhances dopamine release in the frontal cortex. Brain Res 52:413-418.
20. D'Angio M, Serrano A, Driscoll P, Scatton B (1988). Stressful environmental stimuli increase extracellular DOPAC levels in the prefrontal cortex of hypoemotional (Roman high-avoidance) but not hyperemotional (Roman low-avoidance) rats. An in vivo voltammetric study. Brain Res 451:237-247.
21. Davis M (1990). Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect. Pharmacol Ther 47:147-165.
22. De Oliveira AR, Reimer AE, Brandão ML (2006). Dopamine D2 receptor mechanisms in the expression of conditioned fear. Pharmacol Biochem Behav 84:102-111.
23. De Oliveira AR, Reimer AE, Brandão ML (2009). Role of dopamine receptors in the ventral tegmental area in conditioned fear. Behav Brain Res 199:271-277.
24. De Oliveira AR, Reimer AE, Macedo CE, Carvalho MC, Silva MA, Brandão ML (2011). Conditioned fear is modulated by D2 receptor pathway connecting the ventral tegmental area and basolateral amygdala. Neurobiol Learn Mem 95:37-45.
25. De Oliveira AR, Reimer AE, Reis FM, Brandão ML (2013). Conditioned fear response is modulated by a combined action of the hypothalamic- pituitaryadrenal axis and dopamine activity in the basolateral amygdala. Eur Neuropsychopharmacol 23:379-389.
26. Eilam D, Talangbayan H, Canaran G, Szechtman H (1992). Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology (Berl) 106:447-454.
27. Fadok JP, Dickerson TM, Palmiter RD (2009). Dopamine is necessary for cuedependent fear conditioning. J Neurosci 29:11089-11097.
28. Fadok JP, Darvas M, Dickerson TM, Palmiter RD (2010). Long-term memory for pavlovian fear conditioning requires dopamine in the nucleus accumbens and basolateral amygdala. PloS One 5:1-6.
29. Fallon JH, Kozielli DA, Moore RY (1978). Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532.
30. Fanselow MS, LeDoux J (1999). Why we think plasticity of the human brain underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23:229-232.
31. Feenstra MGP, Botterblom MHA (1996). Rapid sampling of extracellular dopamine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res 742:17-24.
32. Feenstra MGP, Botterblom MHA, Van Uum JFM (1995). Novelty-induced increase in dopamine release in the rat prefrontal córtex in vivo: inhibition by diazepam. Neurosci Lett 189:81-84.
33. Fendt M, Fanselow MS (1999). The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 23:743-760.
34. Grace AA, Rosenkranz JA (2002). Regulation of conditioned responses of basolateral amygdala neurons. Physiol Behav 77:489-493.
35. Hamner MB, Diamond BI (1993). Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry 33:304-306.
36. Hitchcock J, Davis M (1986). Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav Neurosci 100:11-22.
37. Houlihan DJ (2011). Psychostimulant treatment of combat-related posttraumatic stress disorder. J Psychopharmacol 25:1568-1572.
38. Ida Y, Tsuda A, Sueyoshi K, Shirao I, Tanaka M (1989). Blockade by diazepam of conditioned fear-induced activation of rat mesoprefrontal dopamine neurons. Pharmacol Biochem Behav 33:477-479.
39. Ikemoto S, Wise RA (2004). Mapping of chemical trigger zones for reward. Neuropharmacology 47:90-201.
40. Indovina I, Robbins TW, Núñez-Elizalde AO, Dunn BD, Bishop SJ (2011). Fearconditioning mechanisms associated with vulnerability to anxiety in humans. Neuron 69:563-571.
41. Kim JJ, Fanselow MS (1992). Modality-specific retrograde amnesia of fear. Science 256:675-677.
42. Kurashima M, Yamada K, Nagashima M, Shirakawa K, Kurukawa T (1995). Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats. Pharmacol Biochem Behav 52:503-508.
43. LeDoux J (2003). The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23:727-738.
44. Li Y, Fang F, Wang X, Lei H (2009). Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging. Magn Reson Imaging 27:293-299.
45. Maren S (1999). Neurotoxic or electrolytic lesions of the ventral subiculum produce deficits in the acquisition and expression of Pavlovian fear conditioning in rats. Behav Neurosci 113:283-290.
46. Maren S, Holt WG (2004). Hippocampus and Pavlovian fear conditioning in rats: muscimol infusions into the ventral, but not dorsal, hippocampus impair the acquisition of conditional freezing to an auditory conditional stimulus. Behav Neurosci 118:97-110.
47. Maren S, Aharonov G, Fanselow MS (1996). Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. Behav Neurosci 110:718-726.
48. Martinez RCR, de Oliveira AR, Macedo CE, Molina VA, Brandão ML (2008). Involvement of dopaminergic mechanisms in the nucleus accumbens core and shell subregions in the expression of fear conditioning. Neurosci Lett 446:112-116.
49. McDevitt JT, Setler PE (1981). Differential effects of dopamine agonists in mature and immature rats. Eur J Pharmacol 72:69-75.
50. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998). Dopamine receptors: from structure to function. Physiol Rev 8:189-225.
51. Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M, et al. (2009). From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci 29:12236-12246.
52. Nader K, Ledoux JE (1999). Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113:891-901.
53. Oades RD, Halliday GM (1987). Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165.
54. Ohman A, Mineka S (2001). Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev 108:483-522.
55. ParéD, Quirk GJ, LeDoux JE (2004). New vistas on amygdala networks in conditioned fear. J Neurophysiol 92:1-9.
56. Paxinos G, Watson C (2007). The rat brain in stereotaxic coordinates. 5th ed. San Diego: Academic Press.
57. Pezze MA, Feldon J (2004). Mesolimbic dopaminergic pathways in fear conditioning. Progr Neurobiol 74:301-320.
58. Pezze MA, Heidbreder CA, Feldon J, Murphy CA (2001). Selective responding of nucleus accumbens core and shell dopamine to aversively conditioned contextual and discrete stimuli. Neuroscience 108:91-102.
59. Pezze MA, Bast T, Feldon J (2003). Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb Cortex 13: 371-380.
60. Phelps EA, LeDoux JE (2005). Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48:175-187.
61. Phillips RG, LeDoux JE (1992). Differential contribution of amygdale and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274-285.
62. Quinn JJ, Loya F, Ma QD, Fanselow MS (2005). Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus 15:665-674.
63. Reimer AE, de Oliveira AR, Brandão ML (2008). Selective involvement of GABAergic mechanisms of the dorsal periaqueductal gray and inferior colliculus on the memory of the contextual fear as assessed by the fear potentiated startle test. Brain Res Bull 76:545-550.
64. Reis FLV, Masson S, de Oliveira AR, Brandão ML (2004). Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests. Pharmacol Biochem Behav 79:359-365.
65. Rimondini R, FerréS, Giménez-Llort L, Ogren SO, Fuxe K (1998). Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur J Pharmacol 347:153-158.
66. Rodrigues SM, LeDoux JE, Sapolsky RM (2009). The influence of stress hormones on fear circuitry. Annu Rev Neurosci 32:289-313.
67. Roth RH (1984). CNS dopamine autoreceptors: distribution, pharmacology, and function. Ann N Y Acad Sci 430:27-53.
68. Santos JM, Gárgaro AC, de Oliveira AR, Masson S, Brandão ML (2005). Pharmacological dissociation of moderate and high fear as assessed by freezing behavior and fear-potentiated startle. Eur Neuropsychopharmacol 15:239-246.
69. Seeman P (1980). Brain dopamine receptors. Pharmacol Rev 32:229-313.
70. Skirboll LR, Grace AA, Bunney BS (1979). Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80-82.
71. Stuchlik A, Rehakova L, Rambousek L, Svoboda J, Vales K (2007). Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task. Neurosci Res 58:133-139.
72. Swanson LW (1982). The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321-353.
73. Vallone D, Picetti R, Borreli E (2000). Structure and function of dopamine receptors. Neurosci Biobehav Rev 24:125-132.
74. Volkow ND, Fowler JS, Wang GJ (2002). Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13:355-366.
75. Wedzony K, Mackowiak M, Fijal K, Golembiowska K (1996). Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists. Synapse 24:240-247.
76. Wise RA (2009). Roles for nigrostriatal - not just mesocorticolimbic - dopamine in reward and addiction. Trends Neurosci 32:517-524.
77. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JMD, Netto CA, Achaval A (2005). A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16:58-64.
78. Yokoyama M, Suzuki E, Sato E, Maruta S, Watanabe S, Miyaoka H (2005). Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett 379:37-41.
79. Zweifel LS, Fadok JP, Garelick MG, Jones GL, Dickerson TM, Allen JM, et al. (2011). Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci 14:620-626.